• Vertex Pharmaceuticals average ebitda margin for 2023 was 42.86%, a 8.98% decline from 2022.
• Vertex Pharmaceuticals average ebitda margin for 2022 was 47.09%, a 16.42% decline from 2021.
• Vertex Pharmaceuticals average ebitda margin for 2021 was 40.45%, a 5.34% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.